EPA and DHA, the two long-chain omega-3 fatty acids found mainly in seafood, influence health across a surprisingly wide range of systems, from the cardiovascular system and the brain to the joints, skin, and possibly the pace of cellular aging itself. Their benefits trace largely to a shared mechanism: they get built into cell membranes throughout the body and shift the balance of inflammatory signaling molecules those cells produce. But EPA and DHA are not interchangeable, and knowing where each one matters, how much evidence backs the various claims, and what the real risks are gives you a much more useful picture than the generic “fish oil is good for you” advice.
Why Your Body Cannot Simply Make Its Own
Your body can technically convert alpha-linolenic acid (ALA), the plant-based omega-3 found in flaxseed and walnuts, into EPA and then DHA. In practice, the process is so inefficient that it barely moves the needle. Only a small single-digit percentage of ALA you eat ends up as EPA, and the further conversion from EPA to DHA is even more limited.1PubMed Central. Are all n-3 polyunsaturated fatty acids created equal? One controlled feeding study found that roughly 6 to 10 percent of dietary ALA was converted to EPA, with no significant change in conversion all the way to DHA regardless of diet composition.2The American Journal of Clinical Nutrition. Conversion of α-linolenic acid in humans is influenced by the absolute amounts of α-linolenic acid and linoleic acid in the diet and not by their ratio This is why dietary guidelines and researchers focus on preformed EPA and DHA from marine sources rather than relying on ALA-rich plant foods to do the job.
The Anti-Inflammatory Engine
When you eat EPA and DHA consistently, they gradually replace some of the arachidonic acid normally sitting in your cell membranes. Arachidonic acid is the raw material for a range of pro-inflammatory signaling molecules. With more EPA and DHA in those membranes and less arachidonic acid, the inflammatory signals your cells produce shift in character. EPA and DHA also give rise to specialized compounds called resolvins and protectins, which actively help resolve inflammation rather than just dampening it.3PubMed Central. Omega-3 fatty acids and inflammatory processes 4PubMed Central. Controlled formation of mono- and dihydroxy-resolvins from EPA and DHA using soybean 15-lipoxygenase This dual action, producing fewer inflammatory signals while generating more clean-up signals, underpins many of the downstream health effects.
Triglycerides and Heart Health
The most clinically established benefit of EPA and DHA is reducing blood triglycerides. At prescription doses of around 4 grams per day, they can cut triglyceride levels by 30 percent or more. The American Heart Association recognizes prescription omega-3s as an effective option for managing high triglycerides, either alone or alongside other lipid-lowering drugs.5PubMed. Omega-3 Fatty Acids for the Management of Hypertriglyceridemia: A Science Advisory From the American Heart Association The mechanism involves not just reduced production of triglyceride-rich particles in the liver but also a recently discovered pathway: omega-3-derived compounds that inhibit fat absorption in the gut, which in animal models lowered plasma triglycerides and protected against liver fat accumulation.6PubMed Central. Triglyceride lowering by omega-3 fatty acids: a mechanism mediated by N-acyl taurines
One important nuance: EPA and DHA are not identical for lipid management. A randomized trial comparing the two head-to-head found that DHA significantly reduced blood triglycerides, while EPA alone did not produce a measurable drop in that study.7The American Journal of Clinical Nutrition. EPA and DHA have divergent effects on serum triglycerides and lipogenesis, but similar effects on lipoprotein lipase activity: a randomized controlled trial However, the AHA advisory notes that in large-scale clinical use, both formulations appear roughly comparable for triglyceride lowering.
A bigger controversy centers on whether omega-3s reduce heart attacks and strokes. The REDUCE-IT trial, using a purified EPA product, showed a meaningful reduction in major cardiovascular events. But the STRENGTH trial, which tested a combination of EPA and DHA, found no such benefit.8PubMed Central. Unraveling the discrepancies between REDUCE-IT and STRENGTH trials with omega-3 fatty acids: new analytical approaches Researchers continue to argue about whether the discrepancy reflects a genuine advantage of EPA alone, differences in the control oils used, or something else entirely. For now, the evidence for hard cardiovascular event reduction is strongest for high-dose EPA specifically.
Brain Health and Cognitive Decline
DHA is a major structural component of brain cell membranes, so it is no surprise that researchers have been probing its connection to cognitive function for decades. The evidence is most consistent for long-term dietary patterns rather than short supplement trials. A large review of 48 longitudinal studies involving over 100,000 participants found that higher dietary omega-3 intake was associated with roughly a 20 percent lower risk of dementia or cognitive decline. DHA intake showed the clearest association, and each additional 0.1 gram per day of DHA or EPA was linked to an 8 to 10 percent lower risk of cognitive decline.9PubMed Central. The Relationship of Omega-3 Fatty Acids with Dementia and Cognitive Decline: Evidence from Prospective Cohort Studies of Supplementation, Dietary Intake, and Blood Markers
A clinical trial specifically testing 900 milligrams per day of algal DHA in healthy older adults with age-related cognitive decline found improvements in learning and memory tasks over six months compared to placebo.10PubMed. Cognitive and cardiovascular benefits of docosahexaenoic acid in aging and cognitive decline The caveat is that once Alzheimer’s disease has progressed significantly, supplement trials have generally not shown reversal. The protective window appears to be earlier, before substantial neurodegeneration sets in.
Depression and Mood
The relationship between omega-3s and depression is one area where EPA and DHA diverge sharply. Two meta-analyses, looking at the question from different angles, converge on the same conclusion: EPA-dominant formulations reduce depressive symptoms, while DHA-dominant formulations do not. Supplements with more than 50 percent EPA, and particularly pure EPA formulations, showed significant antidepressant effects, whereas pure DHA supplements showed essentially zero effect.11PubMed. EPA but not DHA appears to be responsible for the efficacy of omega-3 long chain polyunsaturated fatty acid supplementation in depression: evidence from a meta-analysis of randomized controlled trials A more recent meta-analysis confirmed this, finding that EPA-pure and EPA-major formulations at doses up to 1 gram per day showed clinical benefit, while DHA-pure and DHA-major formulations did not.12PubMed Central. Efficacy of omega-3 PUFAs in depression: A meta-analysis
The effects were modest in size but consistent, and the benefits were more pronounced in people who already had significant depressive symptoms. This is not a replacement for standard treatment, but it suggests EPA has a meaningful adjunctive role, and it underscores how differently these two fatty acids behave.
Pregnancy and Infant Development
DHA is the dominant omega-3 in brain tissue, and the fetal brain accumulates it rapidly during the third trimester. That makes a pregnant woman’s DHA status a matter of genuine developmental importance. The placental supply of DHA during this critical window supports the structural and functional development of the growing brain.13PubMed Central. Maternal Docosahexaenoic Acid Status during Pregnancy and Its Impact on Infant Neurodevelopment DHA supplementation during pregnancy has also been linked to reductions in the risk of preterm birth and low birth weight.14Exploration of Neuroprotective Therapy. Omega-3 fatty acids and fetal brain development: implications for maternal nutrition, mechanisms of cognitive function, and pediatric depression
The picture gets murkier when you ask whether supplementation translates into measurably better cognitive outcomes for the child. A well-designed randomized trial found that children of mothers who took DHA during pregnancy did not score higher on cognitive tests overall, although fewer children in the DHA group showed signs of delayed cognitive development. Interestingly, the study found a differential response by sex: girls in the DHA group actually had lower language scores, while boys showed no difference.15JAMA. Effect of DHA Supplementation During Pregnancy on Maternal Depression and Neurodevelopment of Young Children: A Randomized Controlled Trial The perinatal benefits of DHA are well-supported, but the cognitive payoff for the child is harder to pin down in trials, possibly because measuring subtle developmental advantages is inherently difficult.
Joint Inflammation and Rheumatoid Arthritis
For people living with rheumatoid arthritis, omega-3s offer one of the more tangible everyday benefits. Clinical studies show they can reduce the number of swollen and tender joints.16PubMed Central. The Effect of Omega-3 Fatty Acids on Rheumatoid Arthritis In one trial, patients taking high-dose fish oil experienced significant decreases in tender joints, morning stiffness (dropping by over an hour on average), and physician-assessed pain scores. After the anti-inflammatory drug diclofenac was discontinued, the fish oil group maintained improvements while the corn oil control group did not.17PubMed. Effects of high-dose fish oil on rheumatoid arthritis after stopping nonsteroidal antiinflammatory drugs. Clinical and immune correlates Animal model work suggests EPA is particularly potent here, reducing pro-inflammatory cytokines and suppressing key inflammatory signaling pathways in arthritic joints.18PubMed Central. Eicosapentaenoic acid and docosapentaenoic acid monoglycerides are more potent than docosahexaenoic acid monoglyceride to resolve inflammation in a rheumatoid arthritis model
Skin and UV Protection
An underappreciated benefit of EPA and DHA relates to skin. In a study of patients with polymorphic light eruption (a common sun-sensitivity condition), three months of fish oil supplementation nearly doubled the dose of UVB radiation needed to cause sunburn and reduced sensitivity to UVA-triggered rashes. The effect appeared to work by lowering prostaglandin E2 levels in the skin, one of the inflammatory molecules that drives the redness and swelling of sunburn.19PubMed. Dietary fish oil reduces basal and ultraviolet B-generated PGE2 levels in skin and increases the threshold to provocation of polymorphic light eruption Animal studies reinforce this finding. Mice with adequate omega-3 status showed less skin barrier damage and less abnormal skin structure after repeated UV exposure compared to omega-3-deficient mice.20Prostaglandins, Leukotrienes and Essential Fatty Acids. Omega-3 fatty acids mitigate skin damage caused by ultraviolet-B radiation This is not a sunscreen replacement, but it suggests that omega-3 status contributes to the skin’s built-in defenses against UV damage.
Muscle Protein and Exercise
Athletes and older adults concerned about muscle loss have been interested in omega-3s because of research showing that EPA and DHA incorporation into muscle cell membranes is linked to enhanced protein synthesis signaling and improved mitochondrial function.21PubMed Central. The Influence of Omega-3 Fatty Acids on Skeletal Muscle Protein Turnover in Health, Disuse, and Disease In a controlled trial of older adults, omega-3 supplementation did not change the baseline rate of muscle protein synthesis but significantly amplified the muscle-building response when amino acids and insulin were provided, essentially making the muscle more responsive to the signals that trigger growth.22PubMed Central. Dietary omega-3 fatty acid supplementation increases the rate of muscle protein synthesis in older adults: a randomized controlled trial
However, a systematic review and meta-analysis looking specifically at muscle protein synthesis rates across multiple studies found no overall effect of omega-3 supplementation on that measure when taken in isolation. The meta-analysis did find a positive effect on whole-body protein synthesis rates, suggesting the benefit may be distributed across tissues rather than concentrated in skeletal muscle.23Nutrition Reviews. The effects of omega-3 polyunsaturated fatty acids on muscle and whole-body protein synthesis: a systematic review and meta-analysis The practical takeaway: omega-3s likely help your body use dietary protein more effectively, especially as you age, but they are not a standalone muscle-building supplement.
Liver Fat
Nonalcoholic fatty liver disease is increasingly common, and omega-3 supplementation has shown promise in reducing liver fat content. Two meta-analyses of clinical trials found that omega-3 treatment produced significant reductions in liver fat compared to controls.24PubMed Central. Effects of Omega-3 Fatty Acid in Nonalcoholic Fatty Liver Disease: A Meta-Analysis 25Journal of Hepatology. Omega-3 supplementation and non-alcoholic fatty liver disease: A systematic review and meta-analysis The effect on liver enzymes was less consistent, with some markers improving and others not reaching significance. And the optimal dose has not been established. Still, the direction of the evidence is encouraging for a condition with limited pharmacological options.
Cellular Aging and Telomere Length
One of the more intriguing findings in omega-3 research involves telomeres, the protective caps on chromosomes that shorten with age. In a study of patients with heart disease followed over five years, those with the highest blood levels of EPA and DHA experienced significantly slower telomere shortening than those with the lowest levels. Each standard deviation increase in EPA plus DHA was associated with a 32 percent reduction in the odds of telomere shortening.26JAMA. Association of Marine Omega-3 Fatty Acid Levels With Telomeric Aging in Patients With Coronary Heart Disease A randomized controlled trial went further: it found that decreasing the ratio of omega-6 to omega-3 fatty acids in the blood, through supplementation, was associated with an increase in telomere length of about 20 base pairs per unit decrease in the ratio.27PubMed Central. Omega-3 Fatty Acids, Oxidative Stress, and Leukocyte Telomere Length: A Randomized Controlled Trial These findings do not prove that fish oil extends lifespan, but they suggest omega-3s may influence one of the biological markers of aging.
The Omega-3 Index and Mortality Risk
Researchers have increasingly focused on measuring EPA and DHA levels in red blood cell membranes, a metric called the Omega-3 Index, as a way to assess someone’s omega-3 status. A pooled analysis of 17 prospective studies found that people in the highest fifth of circulating long-chain omega-3 levels had a 15 to 18 percent lower risk of death from all causes compared to those in the lowest fifth.28Nature Communications. Blood n-3 fatty acid levels and total and cause-specific mortality from 17 prospective studies Data from the Framingham Heart Study showed an even starker contrast: people in the highest quintile of the Omega-3 Index had a 34 percent lower risk of death from any cause compared to those in the lowest quintile.29Journal of Clinical Lipidology. Erythrocyte long-chain omega-3 fatty acid levels are inversely associated with mortality and with incident cardiovascular disease: The Framingham Heart Study Among heart attack patients specifically, an Omega-3 Index below 4 percent was independently associated with double the risk of death within one year.30Circulation: Cardiovascular Quality and Outcomes. Omega-3 Index: An Independent Predictor of 1 Year All-Cause Mortality in Myocardial Infarction (MI) Patients
These are observational associations, and it is possible that omega-3 levels partly reflect an overall healthier diet and lifestyle. But the consistency of the findings across diverse populations, and the biological plausibility given the anti-inflammatory and cardiovascular effects described above, makes this one of the more compelling biomarker stories in nutrition.
Safety and the Atrial Fibrillation Signal
At standard supplement doses of 1 gram per day or less, EPA and DHA have a strong safety record. Digestive complaints like fishy aftertaste and mild GI upset are the most common side effects. But at higher therapeutic doses, a signal has emerged that warrants attention: a meta-analysis of randomized trials found that omega-3 supplementation was associated with a 25 percent increased risk of atrial fibrillation. The risk was significantly elevated at doses above 1 gram per day, with a 49 percent increase, while doses of 1 gram or less did not show a statistically significant increase.31PubMed Central. Omega-3 supplementation linked with atrial fibrillation risk: a meta-analysis This matters because atrial fibrillation raises the risk of stroke. Anyone considering high-dose omega-3s, especially people already at risk for heart rhythm problems, should discuss this with a physician.
Another safety concern is more mundane but widespread: supplement quality. A review of commercially available fish oil products found that about 41 percent exceeded recommended limits for a measure of oxidation, and roughly 27 percent exceeded the total oxidation standard set by the industry’s own voluntary guidelines.32PLoS ONE. Fish oil supplements, oxidative status, and compliance behaviour: Regulatory challenges and opportunities Oxidized fish oil may not deliver the expected benefits and could theoretically cause harm. Choosing products that display third-party testing results or carry quality certifications is one of the few practical steps you can take, since you cannot smell or taste low-level oxidation.
Bioavailability Across Different Sources
Not all omega-3 supplements deliver EPA and DHA equally well. The chemical form matters. In animal studies, DHA delivered as a monoglyceride was absorbed and transported significantly more effectively than the same DHA given as a triglyceride or ethyl ester.33PubMed. Lymphatic absorption of docosahexaenoic acid given as monoglyceride, diglyceride, triglyceride, and ethyl ester in rats This is relevant because many over-the-counter fish oil supplements use the ethyl ester form, which tends to be the least well-absorbed. Prescription omega-3s and higher-quality supplements often use triglyceride or free fatty acid forms.
The krill oil versus fish oil debate generates heated discussion online, but a head-to-head crossover study found that overall 24-hour absorption of EPA plus DHA was similar between a phospholipid-enhanced fish oil and krill oil, though the absorption profiles differed: the fish oil product produced a higher and earlier peak.34PubMed. Comparison of the effects of a phospholipid-enhanced fish oil versus krill oil product on plasma levels of eicosapentaenoic and docosahexaenoic acids after acute administration: A randomized, double-blind, crossover study And for people who prefer to avoid fish-derived products entirely, microalgal oil supplements have been shown to be statistically non-inferior to fish oil for EPA and DHA bioavailability in plasma, making them a reliable plant-based alternative.35PubMed Central. Comparative Bioavailability of DHA and EPA from Microalgal and Fish Oil in Adults
DHA and the Evolutionary Brain
The role of DHA in brain tissue has prompted a long-running academic debate about whether access to seafood was a necessary condition for the evolution of the unusually large human brain. DHA is a primary structural component of the synaptic membranes essential for cognitive function, and because human conversion of plant-based ALA to DHA is so limited, some researchers have argued that our ancestors needed preformed DHA from shore-based diets (fish and shellfish) to support brain growth beyond what is seen in other great apes.36PubMed. Docosahexaenoic acid and shore-based diets in hominin encephalization: a rebuttal Others counter that even the inefficient conversion of ALA, available from a wider variety of terrestrial plant foods, appears sufficient for normal brain development and maintenance in modern humans, and that physiological adaptations during pregnancy and infancy may compensate for the low conversion rate.37PubMed. Docosahexaenoic acid biosynthesis and dietary contingency: Encephalization without aquatic constraint 38PubMed. Docosahexaenoic acid, the aquatic diet, and hominin encephalization: difficulties in establishing evolutionary links
The debate remains unresolved, but it highlights something practical: DHA is so important to the brain that researchers seriously argue about whether an entire line of human evolution depended on access to it. That context lends weight to the modern evidence linking DHA intake to cognitive health. Whether or not our ancestors needed fish to evolve bigger brains, modern research consistently shows that people who consume more DHA tend to keep those brains healthier for longer.
When EPA and DHA Play Different Roles
If there is one recurring theme in the research, it is that EPA and DHA are not interchangeable molecules despite being lumped together on supplement labels. DHA is primarily structural: it is the dominant omega-3 in the brain, retina, and cell membranes, making it essential during fetal development and for long-term neurological and visual health.39PubMed Central. Raman Spectroscopic Imaging of Cholesterol and Docosahexaenoic Acid Distribution in the Retinal Rod Outer Segment EPA, meanwhile, appears to be the more functionally active molecule for resolving inflammation and modulating mood. Its advantages are clearest in the depression and arthritis literature, where EPA-dominant formulations consistently outperform DHA-dominant ones.
For triglyceride lowering, the evidence is mixed on which molecule deserves more credit, though both contribute. For cardiovascular event reduction specifically, the only large trial showing clear benefit used purified EPA. And for brain structure and fetal development, DHA takes the lead. If you are choosing a supplement for a specific purpose, the EPA-to-DHA ratio matters more than the total milligrams on the label. A general-purpose supplement with a balanced ratio covers the broadest range of benefits, but someone targeting mood or joint inflammation might look for an EPA-dominant product, while someone focused on pregnancy or cognitive aging would lean toward DHA.